|
|
| YUM! Brands, Inc. (NYSE:YUM) > Financials > Income Statement |
| In Millions of the reported currency, except per share items. | Template: | Standard | | Restatement: | Latest Filings |
| | Period Type: | Annual | | Order: | Latest on Right |
| | Currency: | Reported Currency | | Conversion: | Historical |
| | Units: | S&P Capital IQ (Default) | | Decimals: | Capital IQ (Default) |
| | Source: | Capital IQ & Proprietary Data | |
| Income Statement |
| For the Fiscal Period Ending | Reclassified
12 months
Dec-28-2013 | Reclassified
12 months
Dec-27-2014 | Restated
12 months
Dec-31-2015 | Restated
12 months
Dec-31-2016 | Reclassified
12 months
Dec-31-2017 | 12 months
Dec-31-2018 |
| Currency | USD | USD | USD | USD | USD | USD |
| Revenue | 13,084.0 | 6,587.0 | 6,418.0 | 6,356.0 | 5,878.0 | 5,688.0 |
| Other Revenue | - | - | - | - | - | - |
| Total Revenue | 13,084.0 | 6,587.0 | 6,418.0 | 6,356.0 | 5,878.0 | 5,688.0 |
| Cost Of Goods Sold | 9,659.0 | 4,029.0 | 3,836.0 | 3,666.0 | 3,161.0 | 3,022.0 |
| Gross Profit | 3,425.0 | 2,558.0 | 2,582.0 | 2,690.0 | 2,717.0 | 2,666.0 |
| Selling General & Admin Exp. | 1,397.0 | 1,028.0 | 1,058.0 | 1,105.0 | 971.0 | 904.0 |
| R & D Exp. | - | - | - | - | - | - |
| Depreciation & Amort. | - | - | - | - | - | - |
| Other Operating Expense/(Income) | (9.0) | (3.0) | 4.0 | - | - | - |
| Other Operating Exp., Total | 1,388.0 | 1,025.0 | 1,062.0 | 1,105.0 | 971.0 | 904.0 |
| Operating Income | 2,037.0 | 1,533.0 | 1,520.0 | 1,585.0 | 1,746.0 | 1,762.0 |
| Interest Expense | (129.0) | (143.0) | (153.0) | (331.0) | (473.0) | (496.0) |
| Interest and Invest. Income | - | - | 12.0 | 26.0 | 33.0 | 53.0 |
| Net Interest Exp. | (129.0) | (143.0) | (141.0) | (305.0) | (440.0) | (443.0) |
| Income/(Loss) from Affiliates | 26.0 | - | - | - | - | - |
| Currency Exchange Gains (Loss) | (10.0) | (11.0) | (20.0) | 6.0 | (5.0) | (1.0) |
| Other Non-Operating Inc. (Exp.) | - | - | - | - | - | - |
| EBT Excl. Unusual Items | 1,924.0 | 1,379.0 | 1,359.0 | 1,286.0 | 1,301.0 | 1,318.0 |
| Restructuring Charges | 0 | (3.0) | 1.0 | (24.0) | (55.0) | (19.0) |
| Impairment of Goodwill | (222.0) | - | - | - | - | (12.0) |
| Asset Writedown | (114.0) | (15.0) | (17.0) | - | (2.0) | (1.0) |
| Other Unusual Items | (37.0) | 13.0 | (90.0) | 83.0 | 1,030.0 | 553.0 |
| EBT Incl. Unusual Items | 1,551.0 | 1,374.0 | 1,253.0 | 1,345.0 | 2,274.0 | 1,839.0 |
| Income Tax Expense | 487.0 | 368.0 | 327.0 | 327.0 | 934.0 | 297.0 |
| Earnings from Cont. Ops. | 1,064.0 | 1,006.0 | 926.0 | 1,018.0 | 1,340.0 | 1,542.0 |
| Earnings of Discontinued Ops. | - | 45.0 | 357.0 | 625.0 | - | - |
| Extraord. Item & Account. Change | - | - | - | - | - | - |
| Net Income to Company | 1,064.0 | 1,051.0 | 1,283.0 | 1,643.0 | 1,340.0 | 1,542.0 |
| Minority Int. in Earnings | 27.0 | - | - | - | - | - |
| Net Income | 1,091.0 | 1,051.0 | 1,283.0 | 1,643.0 | 1,340.0 | 1,542.0 |
| Pref. Dividends and Other Adj. | - | - | - | - | - | - |
| NI to Common Incl Extra Items | 1,091.0 | 1,051.0 | 1,283.0 | 1,643.0 | 1,340.0 | 1,542.0 |
| NI to Common Excl. Extra Items | 1,091.0 | 1,006.0 | 926.0 | 1,018.0 | 1,340.0 | 1,542.0 |
| Per Share Items |
| Basic EPS | $2.41 | $2.37 | $2.95 | $4.17 | $3.86 | $4.79 |
| Basic EPS Excl. Extra Items | 2.41 | 2.27 | 2.13 | 2.58 | 3.86 | 4.79 |
| Weighted Avg. Basic Shares Out. | 452.0 | 444.0 | 435.0 | 394.0 | 347.0 | 322.0 |
| Diluted EPS | $2.36 | $2.32 | $2.9 | $4.1 | $3.77 | $4.69 |
| Diluted EPS Excl. Extra Items | 2.36 | 2.22 | 2.09 | 2.54 | 3.77 | 4.69 |
| Weighted Avg. Diluted Shares Out. | 461.0 | 453.0 | 443.0 | 400.0 | 355.0 | 329.0 |
| Normalized Basic EPS | $2.72 | $1.94 | $1.95 | $2.04 | $2.34 | $2.56 |
| Normalized Diluted EPS | 2.67 | 1.9 | 1.92 | 2.01 | 2.29 | 2.5 |
| Dividends per Share | $1.41 | $1.56 | $1.74 | $1.73 | $1.26 | $1.5 |
| Payout Ratio % | 56.4% | 63.7% | 56.9% | 45.3% | 31.0% | 30.0% |
| Supplemental Items |
| EBITDA | 2,758.0 | 1,861.0 | 1,839.0 | 1,895.0 | 1,999.0 | 1,899.0 |
| EBITA | 2,065.0 | 1,546.0 | 1,533.0 | 1,616.0 | 1,779.0 | 1,799.0 |
| EBIT | 2,037.0 | 1,533.0 | 1,520.0 | 1,585.0 | 1,746.0 | 1,762.0 |
| EBITDAR | 3,810.0 | 2,141.0 | 2,093.0 | 2,129.0 | 2,213.0 | 2,050.0 |
| As Reported Total Revenue* | 13,084.0 | 6,587.0 | 6,418.0 | 6,356.0 | 5,878.0 | 5,688.0 |
| Effective Tax Rate % | 31.4% | 26.8% | 26.1% | 24.3% | 41.1% | 16.2% |
| Current Domestic Taxes | 181.0 | 241.0 | 295.0 | 139.0 | 10.0 | 127.0 |
| Current Foreign Taxes | 330.0 | 173.0 | 133.0 | 160.0 | 290.0 | 181.0 |
| Total Current Taxes | 511.0 | 414.0 | 428.0 | 299.0 | 300.0 | 308.0 |
| Deferred Domestic Taxes | 29.0 | (33.0) | (116.0) | 25.0 | 615.0 | (16.0) |
| Deferred Foreign Taxes | (53.0) | (13.0) | 15.0 | 3.0 | 19.0 | 5.0 |
| Total Deferred Taxes | (24.0) | (46.0) | (101.0) | 28.0 | 634.0 | (11.0) |
| Normalized Net Income | 1,229.5 | 861.9 | 849.4 | 803.8 | 813.1 | 823.8 |
| Interest on Long Term Debt | 152.0 | NA | NA | 331.0 | 473.0 | 496.0 |
| Non-Cash Pension Expense | 45.0 | 16.0 | 39.0 | 1.0 | 7.0 | 15.0 |
| Filing Date | Feb-16-2016 | Feb-22-2017 | Feb-22-2018 | Feb-21-2019 | Feb-21-2019 | Feb-21-2019 |
| Restatement Type | RC | RD | RS | RS | RC | O |
| Calculation Type | REP | REP | REP | REP | REP | REP |
| Supplemental Operating Expense Items |
| Advertising Exp. | 607.0 | 261.0 | 253.0 | 260.0 | 245.0 | 131.0 |
| General and Administrative Exp. | 1,397.0 | 1,028.0 | 1,058.0 | 1,099.0 | 947.0 | 890.0 |
| R&D Exp. | 31.0 | 25.0 | 25.0 | NA | NA | NA |
| Net Rental Exp. | 1,052.0 | 280.0 | 254.0 | 234.0 | 214.0 | 151.0 |
| Imputed Oper. Lease Interest Exp. | 366.1 | 101.2 | 85.5 | 94.9 | 85.6 | 60.3 |
| Imputed Oper. Lease Depreciation | 685.9 | 178.8 | 168.5 | 139.1 | 128.4 | 90.7 |
| Stock-Based Comp., G&A Exp. | - | - | - | 30.0 | 18.0 | (3.0) |
| Stock-Based Comp., Unallocated | 49.0 | 45.0 | 46.0 | 50.0 | 47.0 | 53.0 |
| Stock-Based Comp., Total | 49.0 | 45.0 | 46.0 | 80.0 | 65.0 | 50.0 |
| * Occasionally, certain items classified as Revenue by the company will be re-classified as other income if it is deemed to be non-recurring and unrelated to the core business of the firm. This field shows Total Revenue exactly as reported by the firm on its consolidated statement of income. |
| Note: For multiple class companies, per share items are primary class equivalent, and for foreign companies listed as primary ADRs, per share items are ADR-equivalent. |